Introduction Basal and squamous cell carcinoma are the most frequently found skin cancers in the caucasian population. In the last years it has been noticed that the frequency of these types of cancers increased with 10%. Even if these tumors are considered low aggressive cancers because they have a reduced risk of metastasis, they produce a high local morbidity by infi ltration and destruction [1] . Th e treatment of these lesions has to fulfi ll some important objectives: destruction of tumoral tissue (recurrence appears because of incomplete tumor destruction), healthy tissue sparing, good esthetic result, low treatment cost, because of the high frequency of these tumors.
Introduction
excision. "Wait and see" attitude is considered of high risk because of high morbidity and diffi cult treatment in case of recurrence.
Micrographic surgery. Mohs surgery
Th ese techniques are using frozen sections for the tumor margin assessment. Sections are made parallel with the skin, diff erent from the classic histology technique, where sections are made perpendicular in a broad leaf fashion from the specimen. Almost total margins control is obtained using these techniques. Micrographic surgery is recommended for high risk carcinoma. Th ere are multiple techniques of micrographic surgery, most studies are referring to the Mohs method, which was the fi rst method described over fi fty years ago [5] .
Radiotherapy
Th ere are many controversies regarding the use of radiotherapy (RT) for the treatment of skin carcinoma. Two opposite opinion exist, one which advocates the use of RT in a great number of cases and the second which describes RT as an adjuvant therapy after surgery. Th e NCCN (U.S. National Comprehensive Cancer Network) guideline recommends a consensus of these two opposite opinions. RT as fi rst intention therapy is reserved for patients over 60 years because of the possible side eff ects [6] . RT is avoided in genetic syndromes, such as xeroderma pigmentosum, collagenosis, Gorlin's syndrome.
Superfi cial therapies
Th ese types of therapies comprise: topical application of 5FU (fl uorouracil) or imiquimod, PDT (photodynamic therapy), cryotherapy. Recurrence rates are higher for these therapies, when compared with surgery and radiotherapy [7] .
Another group of therapies are new emerging therapies. Th ey comprise systemic therapies, such as Vismodegib, a hedgehog signaling pathway inhibitor. Th ese new therapies are used for Gorlin's syndrome and for metastatic diseases.
Th e majority of BCC are nodular type and they appear at the facial level in patients over 60 years old. For this type of tumors superfi cial therapies do not have indications because of the high risk of relapse. RT is not feasible for high volume tumors and for locations close to vital structures, such as the eyeball. Th e therapy with the highest healing rate reported in the scientifi c literature, for the BCC, is micrographic surgery [8, 9] .
Aim
Th e aim of this study is to determine the benefi ts and the disadvantages of using micrographic surgery in the treatment of facial BCC. Classic surgery was compared with micrographic surgery using a prospective randomized comparative study for two groups of patients. BCCs included in the study had to fulfi ll three criteria from the list of indications for micrographic surgery (Table I) . BCCs with high risk of relapse were included.
Patients and methods
Th e study took place at the Dermatology Clinic ClujNapoca from May 2010 until September 2012. Patients included in the study were divided into two groups.
Th e fi rst group was treated with micrographic surgeryMohs surgery (MS) method. A number of 49 patients who presented 52 tumors were included in this group. Th ree patients presented two tumors, the rest of them presented one tumor.
In the second group were included 52 patients with 53 tumors. Th ese patients were treated by classic surgery (CS).
Tumors were excised by four dermatologists and they were histopathologically evaluated by two anatomopathologists.
Inclusion criteria
We included patients who at clinical inspection presented lesions diagnosed as BCC and the diagnosis had to be confi rmed by histology. Tumors had to be on the face and had to have at least two other criteria from Table I .
Th e criteria presented in Table I are indicating an aggressive tumor behavior, which normally has an indication for micrographic surgery [10, 11] . Primary tumors with a diameter smaller than 0.3 cm were not included in the study, because they were considered of low risk no matter what other characteristics they had.
Method
Patients were seen in the ambulatory unit of the Dermatology Clinic Cluj-Napoca by the dermatology specialist. Patients who presented suspected lesions of BCC and fulfi lled the inclusion criteria mentioned above were asked whether they want to participate in the study. If they accepted and signed the acceptance form, they continued the evaluation with the authors of the study. Patients included were assigned to one of the two groups randomly, so that no consecutive patients would be in the same group. If the clinical diagnosis did not correspond with the histopathological diagnosis, the lesion was later excluded.
Patients who were assigned to the Mohs surgery (MS) group had their lesions measured and photographed. Two diameters were noted. Tumor clinical margin was drawn using gentian violet by clinical observation in the operation room under surgical light. Surgical safety margin was established at 2 mm for this group and marked on the skin before anesthesia was administered. Local anesthesia was used with a mixture of lidocaine and adrenaline 1:200.000. Th e Mohs protocol was followed, so the fi rst excision had to be made with 2 mm surgical safety margin [9] . Th ere are no specifi c recommendations for the depth of excision in the Mohs protocol. For thin tumors the excision was performed until the subcutaneous tissue. For thicker tumors or with infi ltrative pattern, the subcutaneous tissue which seemed clinically aff ected was excised, and in rare cases the underlying fascia was reached. After skin incisions were made, the 12 o'clock point was marked with a tread on the specimen. Th is point corresponded in vivo with the superior pole. Skin incisions were made at a 45° angle, so the resulted specimen had a conic shape with the deep plan smaller than the upper epidermic plan. Th is shape is important, because specimens with this form allow having the peripherical margin in the same plane with the deep surface [12] . In the histopathology laboratory the specimen was processed according to Mohs surgery technique. Bigger specimens were divided and marked with colors which were drawn on a map. Sections were made at a thickness of 6-8 μm, parallel with the epidermal layer. Slides were stained with hematoxylineosine (HE) (Figure 1 ).
Slides were interpreted by the anatomopathologist along with the surgeon to reduce orientation errors. If tumor cells were found on the fi rst slides, the exact position was marked on the map. In this way re-excision was performed at a limited site, exactly where the tumor infi ltrated margin was. A Mohs cycle took about 45 minutes. Th is process was repeated until tumor free slides were found at examination.
Classic surgical excisions (CS) were also done in local anesthesia with lidocaine and adrenaline 1:200.000. Here the surgical margins were set at 4 mm according to the NCCN guidelines. Th ese margins were used as often as possible, but in cases of vicinity with vital structures e.g. eyelids, eyeball, margins were taken as close as possible to 4 mm. Th e superior pole of the specimen was marked with a thread and sent to pathology. In the anatomopathology laboratory the specimens followed the classic paraffi n process, which comprises cutting slides from the specimen area where the tumor is close to the surgical margin. Th is evaluation is made by naked eye. Slides were stained with H-E and the result was available in about two weeks. Patients where the excisional margins were infi ltrated by tumor were not treated by re-excision; instead this group of patients was followed more closely. If a recurrence was diagnosed, the patients were treated by MS.
Defect reconstruction was done immediately for the CS group. For the MS groups reconstruction was made only after the margins were free of tumor; this meant between a few hours to 2-3 days from the moment of initial excision, according to the number of Mohs stages. Methods of reconstruction used varied from persecundam healing to local fl aps for bigger defects. Methods of reconstruction were chosen according to defect characteristics and age, comorbidities, patient wish.
Patients were scheduled for follow-up and the evaluation of effi cacy of the two surgical methods was done. Follow-ups were scheduled at every 6 months in the fi rst year and then yearly. Th e total follow-up duration was set to 5 years. Th e mean follow-up period was calculated from the time of surgery to the last follow-up visit which the patient attended. Relapses were registered if they were confi rmed by biopsy.
For each case total treatment time (duration of excision without reconstruction time) was registered. For the MS the time of each excision from the Mohs stages was summed. For the patients included in the study also the socio-demographic characteristics were noted, which are presented in Table I .
Results
One-hundred one patients were included in the study from May 2010 to September 2012. In total 105 tumors were treated with both methods. Four patients had two tumors.
Th e mean age for the CS group was 70 years, interval between 27 and 87 years. In CS group we had 52 patients with 53 tumors, one had two lesions. Seventeen patients were female and 35 male. Th e mean surface was 0.9 cm 2 , interval 0.09-2.95 cm 2 . From the 53 tumors 8 (15%) were incompletely excised and the rest were completly excised according to the histopathology report. Characteristics of incompletely excised tumors can be seen in Table II . Histologic subtypes can be seen in Table III . Th e most frequent subtype was nodular, 34 tumors. Th e most frequent localization was on the cheek and nose. Four tumors were recurrent, 49 were primary tumors.
In the MS group 49 patients had 52 lesions. Mean age was 66 years, interval between 35 and 97 years. Twenty-two patients were male and they had 24 tumors, 27 patients were female with 28 tumors. Th ree patients presented two lesions each. Nine (17.3%) tumors were recurrent, treated before with CS or electrocauterization. Characteristics of recurrent tumors are presented in Table IV .
Patients treated by MS were initially excised with a safety margin of 2-3 mm. After fi rst stage 16 (30%) tumors had been completely excised, 36 tumors had to be re-excised with another 2-3 mm at the level of infi ltrated margin. After the second excision 47 (90.4%) tumors were completely excised. Five tumors (9.6%) needed 7 mm surgical margin. Two patients were not free of tumor after the third excision, they continued treatment with RT. Localization of tumor infi ltration and the number of Mohs stages can be seen in Table V . Th e characteristics of tumors which needed more than 5 mm of marginal resection are shown in Table VI .
Follow-up mean period was one year for MS, interval between 2 months the shortest and 1.8 years. For the group treated with CS follow-up mean period was 1.1 years, interval between 4 months and 2.3 years. All patients were at least once evaluated post treatment. Compliance for follow-up visits was low, 6 patients were lost, they didn't complete any visit of follow-up, and they were not included in the fi nal results. Th e the most frequently used reconstruction method for both groups taken together and separately was local fl ap ( Figure 2) . Th e second most frequent method was skin graft, and then combined methods.
Two relapses (3.7%) in the CS group and zero relapses in MS until September 2012 were registered, but the follow-up will continue for 5 years in both groups. Relapses were primary tumors, nodular and infi ltrative subtypes and both of them were localized at the nose level. Nodular subtype presented tumor infi ltration of the margins at the histopathology examination. Th e second patient was free of tumor according to the histopathology report. Th ese two patients were further treated by MS and became part of this group.
Treatment time (surgical excision) was 21 minutes for the CS group and 47 minutes for the MS group.
Discussions
Th e aim of the study was to compare the post therapeutic outcome after CS and MS, and to emphasize the best treatment method for aggressive facial BCC. Results regarding recurrence after each surgical method discussed here are not conclusive, because the follow-up period has to be minimum two years in each group. Th e majority of recurrences appear in the fi rst two years after the treatment [13] . For some authors the recurrence peak is at two years post treatment. For others like Rowe et al. less than 1/3 of recurrence cases are evident in the fi rst year, and only half of the cases will appear in the fi rst two years post treatment. Two thirds of the recurrences are diagnosed in the fi rst 3 years.
In our study the mean follow-up was one year for MS group and 1.1 years for the CS. For the MS group zero recurrences were noted and for CS group we had two, 3.7%, recurrences in two diff erent patients.
For the CS recurrence rates reported in the literature, they can vary widely. In a review Th issen et al. did a metaanalysis from three articles which accounted for more than 1500 patients. Recurrence rate calculated at fi ve years was between 3.2-8% for primary tumors [14] . In a study dedicated to BCC relapses after CS, Silverman et al. showed the relapses rates for each region on the body: for the extremities and body rates were 0.7%, and for head and neck depending on the diameter: < 6 mm 3.2%, 6-9 mm 8%, > 10 mm 9% [15] .
In our study, surgical safety margin was 4 mm for the CS group. In most of the studies cited in the scientifi c literature this margin was 3 mm [15, 16] . Th is safety margin of 4 mm can produce lower recurrences on long term. For the 4 mm margin tumor clearance is achieved in 95% of the cases where diameter was smaller than 2 cm [17] . Th ese results were also given by numerous studies which used micrographic surgery to estimate tumor clearance for a certain safety surgical margin. Considering these results for a 4 mm margin using CS treatment method, the relapse should be less than 5% after two years follow-up. In our study the mean relapse rate after 1 year follow-up was 3.7%. In a study of over 844 cases in France which used 4 mm safety margin and CS for tumors with a mean diameter of 13 mm localized over the entire body, the relapse rate was 3.8%. Th e mean follow-up was 36 months [18] .
A diff erent approach in our study compared with others was the management of the cases with tumor infi ltration of the margins after CS. In our study these cases were observed and treated by MS only if a histologically confi rmed relapse occurred. In other studies, Smeets et al., who reported lower relapse rates (3% at 30 months) [19] , additional excision was performed with a 3 mm margin if margins were infi ltrated. If margins were still tumor positive, the patient was switched to MS. In this way relapses were reduced substantially. Relapses can appear in cases where margins were false negative and further treatment was not needed. False negative results are possible for CS because the histology is classic broad leaf type. According to some studies, the rate of false negative histologic results is 20-22% for CS [15] . In fact, the main diff erences between the two methods of surgical treatment are the number of false negative results from the histological examination, which is lower for the MS method. Th e diff erence is given by the percent of margin examination, which is around 1% for CS and almost 100% for MS.
Relapse in cases with tumor infi ltration of margins is an issue discussed a lot in the scientifi c literature. Some studies are reporting rates between 8-43% from the tumor positive cases. In a meta-analysis which comprises of 86 studies Gastman et al. shows the mean rate of relapse is 27% from the cases with positive margins. In this study were included 14.000 cases and the surgical safety margin was 3-4 mm [15, 16] .
In our study 15% (8 cases) of the tumors excised by CS had infi ltrated margins and in the scientifi c literature rates reported are between 12-43% [20] . We had 2 relapses from which one case with tumor infi ltrated margins on the initial treatment; this means a rate of 12.5% relapse from tumor positive cases, which is much lower than any other report in the literature. Th is is without any doubt because of the short follow-up in our study.
In our study the most frequent tumor localization with positive margins were: nose, cheek, medial canthus, temporal region and ear. Th ese locations correspond with the reports from literature, as high risk for relapse and incomplete excision.
Not all the patients with positive margins will relapse. It can be considered that some histological reports are false positive and so the number of cases with positive margins is artifi cially increased. Th is can happened if tumor cells are tangent to the surgical margin. Another explanation can be destruction of tumor cells by post-surgery infl ammation and healing process [15, 21] .
Which are the factors for a high risk relapse in patients with tumor positive margins? Localization, size, histologic subtypes are the most important predictive factors [20] . In our group treated by CS, from 8 tumors with positive margins, 3 (37.5%) had an aggressive histologic subtype with a localization that corresponded with dates reported in the literature, for example the nose which is the most common location (Table III) . Size of the tumors with positive margins was smaller than the mean size; this can be explained by the small group and the short followup period.
At the re-excision of the tumor positive margins, tumor cells are found in 50% of the cases [22] . Another study on 1400 BCC treated with CS found tumor cells in the re-excision specimens in 28% of the cases [23] . Limitations for the majority of studies are the classic histological method of examination. For this reason we believe that the actual rates on this issue are higher than those presented, but not 100%.
In case of incomplete excision by CS the attitude recommended by the majority of authors is re-excision. By immediate re-excision avoidance of relapse is achieved. Yet we need to have a tailored approach for each case because less than half of the positive BCC will relapse.
Relapse rate of the tumors treated by MS is 1-2% [19, 14] . Th is low relapse rate is assured by complete tumor excision. Th rough total margins assessment false negative results are reduced. Lesions are excised little by little, obtaining total tumor excision. Th e diff erence of relapse rates between CS and MS are favorable to MS in most of the studies. Th is high effi ciency for MS is secondary to histologic examination of almost 100% of the margins. In our study recurrence was 0 for this group, after one year follow-up.
Th e number of MS stages necessary for free tumor margins including initially excision is 1,78 similar to literature dates [19] . Th e initial surgical safety margin for MS was 2-3 mm and for each stage another 2 mm was excised from the tumor infi ltrated area. After the fi rst excision with 2-3 mm, 30% of the patients were free of tumor. After the second stage, which meant a total of 4-5 mm of surgical margin, 90.4% of the patients were free of tumor. Five patients needed three stages of MS, meaning 7 mm of safety surgical margin. In our study two patients were positive even after three stages. Th ese patients were treated with RT (local radiotherapy) for disease control. Th ese tumors were located on the medial canthus and nasolabial fold. Th e patient with nasolabial fold tumor was treated several times by CS before MS. Probably because of reconstruction with fl aps, tumor became multicentric and it was diffi cult to be treated by MS. Th e second patient had a 2.3 cm diameter tumor located on medial canthus. He had three stages of MS, but tumor infi ltrate was still found in depth. For total tumor excision sacrifi ce of the medial canthal tendon and of the inferior lacrimal canaliculus was needed and the patient refused the intervention. Th e patient was directed to RT.
Tumor characteristics which needed three excisions with MS are presented in Table VI . Th ey present aggressive histologic subtypes (mixed, infi ltrative, morpheaform) and locations with high risk for subclinical invasion (nose, medial canthus, inferior lids, nasolabial fold). Dimensions were higher than the group average. Our dates were similar with those from the scientifi c literature.
Th e most frequent localization was on the nose, 42 tumors (40%) in both groups. Other studies with bigger number of patients are reporting nose as the most frequent localization [24, 25] . Th e nose is also a risk factor for subclinical infi ltration and recurrence [26] . Th e nose localization being the most frequent, local fl ap was the most used method of reconstruction because these produces the best aesthetic results, much better than skin graft or persecundam healing.
Males had a higher incidence of BCC and in our study. Tumors which appeared in males represented 56% from the total number of patients [27] .
Two patients who presented BCC from the MS group presented also melanoma. Some studies are investigating a link between melanoma and BCC and it is demonstrated that patients with BCC have a higher risk for developing melanoma [28] .
Conclusions
After a follow-up of 1 year, the relapse for the MS group is zero and the relapse for CS is 3.7%. Th is is an intermediate result, because a fi nal conclusion is to be issued after a minimum of two years follow-up. Even so, our study demonstrates the superiority of MS for treatment of BCC of the face skin. Th e main disadvantages for MS are: cost and duration. Th e mean time for the MS was 47 minutes and for CS 21 minutes. Th is is the excision time only; reconstruction time was not included, because this should be the same for any surgical method for defects with an equal diameter.
MS remains the gold standard for the treatment of BCC at the head level. MS is the only treatment method which reports healing rates over 95% in the majority of studies. A good selection of the cases is mandatory; MS should be used for aggressive tumors in diffi cult locations and especially on the face.
